Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.6M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
45.5M
-
Shares change
-
-3.01M
-
Total reported value, excl. options
-
$83.1M
-
Value change
-
-$40.3M
-
Put/Call ratio
-
0.13
-
Number of buys
-
56
-
Number of sells
-
-54
-
Price
-
$1.82
Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q3 2024
133 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q3 2024.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.5M shares
of 54.6M outstanding shares and own 83.25% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9.7M shares), FMR LLC (5.87M shares), TANG CAPITAL MANAGEMENT LLC (4.2M shares), Vivo Capital, LLC (4.03M shares), Redmile Group, LLC (3.84M shares), BlackRock, Inc. (2.6M shares), MPM BIOIMPACT LLC (2.41M shares), MILLENNIUM MANAGEMENT LLC (2M shares), VANGUARD GROUP INC (1.88M shares), and GEODE CAPITAL MANAGEMENT, LLC (701K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.